Searchable abstracts of presentations at key conferences in endocrinology

ea0022oc5.2 | Reproduction & Thyroid | ECE2010

The influence of cure of subclinical hyperthyroidism on diastolic diameters of heart chambers and cardiac index

Kaminski Grzegorz , Podgajny Zbigniew , Szalus Norbert

Introduction: Subclinical hyperthyroidism (SH) affects about 1% of population. The diagnosis of this disease leans on the laboratory criteria only: decreased of TSH and normal FT3 and FT4 levels. SH increases mortality mostly due to cardiovascular diseases including arrhythmia and overload of the heart. Enlarging of heart chambers is one of the cause of arrhythmia, and cardiac index is one of indicators of heart after load.Aim: To e...

ea0020p89 | Thyroid | ECE2009

Our experience in visualization of non-radioiodine-avid differentiated thyroid carcinoma (NRADTC)

Podgajny Zbigniew , Kaminski Grzegorz , Szalus Norbert

Introduction: Lack of radioiodine uptake in differentiated thyroid carcinoma (DTC) is a big diagnostic and therapeutic problem. This sign is associated with worse prognosis. In NRADTC patients with elevated thyreoglobulin levels with no evidence of disease in radioiodine scintigraphy, scintigraphy with the somatostatin analog labeled with 99mTc seems to be an alternative imaging method.Aim: Assessment of scintigraphy with the somatostatin anal...

ea0016p680 | Thyroid | ECE2008

The influence of cure of subclinical hyperthyreosis on heart rate and autonomous nervous sytem

Kaminski Grzegorz , Makowski Karol , Dunal Agnieszka , Michalkiewicz Dariusz , Olszak Marlena , Podgajny Zbigniew , Kubik Leszek

Introduction: Subclinical hyperthyreosis (SH) affects about 1.5% population at least. The diagnosis of this disease leans on the laboratory criteria only: decreased of TSH and normal FT3 and FT4 levels. SH increases mortality and there is no unequivocal procedure algorithm to manage patients with this desease.Aim: To estimate an influence of cure of SH on heart rate and on autonomous nervous sytem and to find the relationships between parameters of Holte...

ea0014oc8.5 | Neuroendocrinology clinical | ECE2007

Inoperable pituitary tumours treated with 90Y-DOTA-TATE – initial results

Kaminski Grzegorz , Szalus Norbert , Zielinski Grzegorz , Podgajny Zbigniew , Zgliczynski Wojciech , Kasperlik-Zaluska Anna , Cyperling-Kaminska Joanna , Dziuk Eugeniusz

Introduction: The patients with inoperable hormone - secreting pituitary tumours are treated with cold somatostatin analogues, but it is not always effective. DOTA-TATE preparation is a somatostatin analogue coupled with β (−) emitter 90 Y. The efficacy of the treatment is based on excessive expression of somatostatin receptors (SSTR) in these tumours.The aim of the study: To assess the feasibility of treatment of pituitary tumours ...